John Lusingu mainly investigates Malaria, Plasmodium falciparum, Immunology, RTS,S and Tanzania. His research ties Incidence and Malaria together. His Plasmodium falciparum research is multidisciplinary, incorporating perspectives in Genetics, Receptor, Antibody, Virology and Virulence.
John Lusingu focuses mostly in the field of Virology, narrowing it down to topics relating to Group A and, in certain cases, Gene. He has included themes like Vaccine efficacy and Vaccination in his RTS,S study. His studies examine the connections between Vaccine efficacy and genetics, as well as such issues in Pediatrics, with regards to Randomized controlled trial and Adverse effect.
His primary areas of study are Malaria, Plasmodium falciparum, Immunology, Virology and Tanzania. He does research in Malaria, focusing on Malaria vaccine specifically. His Malaria vaccine study deals with Vaccination intersecting with Circumsporozoite protein.
His work carried out in the field of Plasmodium falciparum brings together such families of science as Antibody, Gene, Pathogenesis and Antigen. Parasite load is closely connected to Disease in his research, which is encompassed under the umbrella topic of Immunology. John Lusingu works mostly in the field of Virology, limiting it down to topics relating to Antigenic variation and, in certain cases, Clone.
The scientist’s investigation covers issues in Malaria, Plasmodium falciparum, Pregnancy, Obstetrics and Tanzania. His Malaria study focuses on Cerebral Malaria in particular. His Plasmodium falciparum research incorporates elements of Immune system, Antibody, Cell biology, Endothelium and Microcirculation.
When carried out as part of a general Pregnancy research project, his work on Gestational age, Birth weight, Full Term and Placental dysfunction is frequently linked to work in Low resource, therefore connecting diverse disciplines of study. John Lusingu interconnects Cohort study, Iron deficiency, Public health, Intrauterine growth restriction and Cohort in the investigation of issues within Obstetrics. His RTS,S research includes elements of Incidence and Vaccine efficacy.
His primary scientific interests are in Malaria, Cerebral Malaria, Plasmodium falciparum, Genotype and Disease. John Lusingu works on Malaria which deals in particular with RTS,S. His research in Cerebral Malaria intersects with topics in Antibody, Pediatrics and Virology.
His Plasmodium falciparum research is multidisciplinary, relying on both Immunoglobulin G, Antiserum, Immune system and Antigen. His work deals with themes such as Parasite load, Anemia and Immunology, which intersect with Genotype. His research integrates issues of Meningitis and Malaria vaccine in his study of Randomized controlled trial.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
Selidji Todagbe Agnandji;Bertrand Lell;Bertrand Lell;Solange Solmeheim Soulanoudjingar;Solange Solmeheim Soulanoudjingar.
The New England Journal of Medicine (2011)
National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010
Anne C.C. Lee;Anne C.C. Lee;Joanne Katz;Hannah Blencowe;Simon Cousens.
The Lancet Global Health (2013)
Severe malaria is associated with parasite binding to endothelial protein C receptor
Louise Turner;Thomas Lavstsen;Sanne S. Berger;Christian W. Wang.
Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure
C. J. Drakeley;P. H. Corran;P. G. Coleman;J. E. Tongren.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Philip Bejon;John Lusingu;Ally Olotu;Amanda Leach.
The New England Journal of Medicine (2008)
Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes.
Anja T.R. Jensen;Pamela Magistrado;Sarah Sharp;Louise Joergensen.
Journal of Experimental Medicine (2004)
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
Daniel E Neafsey;Michal Juraska;Trevor Bedford;David Benkeser.
The New England Journal of Medicine (2015)
Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children
Thomas Lavstsen;Louise Turner;Fredy Saguti;Pamela Magistrado;Pamela Magistrado.
Proceedings of the National Academy of Sciences of the United States of America (2012)
Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21 st standard: Analysis of CHERG datasets
Anne C.C. Lee;Anne C.C. Lee;Naoko Kozuki;Naoko Kozuki;Simon Cousens;Gretchen A. Stevens.
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
Michael T. White;Robert Verity;Jamie T. Griffin;Kwaku Poku Asante.
Lancet Infectious Diseases (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: